GenoMed's West Nile treatment speeds up Texas policeman's recovery from paralysis

GenoMed has announced that a Texas policeman with paralysis from the waist down due to West Nile virus has accelerated his recovery since starting GenoMed's treatment last week.

The patient contracted West Nile virus encephalitis a month ago. On Monday of that week he was fine, but by Friday, his legs were so weak that he could only get around by crawling. Although he was hospitalized for the next two weeks, he showed little improvement and had become discouraged.

Last week, on Thursday afternoon, August 10th, the patient and his physician began GenoMed's protocol. Two days later, on Saturday, August 12th, the patient walked with assistance for 100 steps, compared to only 18 steps on Friday, the day before. Yesterday, Tuesday, August 15th, the patient could easily move the toes in his right foot for the first time, as well as begin to move his right foot sideways.

Said GenoMed's CEO and Chief Medical Officer, David Moskowitz MD, FACP, "This patient's accelerated recovery from West Nile virus reinforces the idea that our treatment should be used early in all patients suspected of West Nile virus encephalitis. It is possible that he might not have progressed to paralysis if his physician had started him on our treatment during the very first week of symptoms." Added Dr. Moskowitz, "Getting the word out about our treatment may literally make the difference between life and death, or in this case a quick recovery versus prolonged paralysis."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative vaccine shields livestock from four strains of foot and mouth disease